Refreshing results…
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Download from aacrjournals.orgAdaptive mutability of colorectal cancers in response to targeted therapies
UploadTRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
UploadMissing publications? Search for publications with a matching author name.